He aha ʻo Adalimumab-aqvh: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

ʻO Adalimumab-aqvh he lāʻau lapaʻau biosimilar e kōkua ana i ka mālama ʻana i kekahi mau maʻi autoimmune ma ka hoʻomaha ʻana i kāu ʻōnaehana pale i ka hana nui. He mana i hana ʻia i loko o ka hale hana o kahi protein maoli e ālai ana i nā hōʻailona mumū kikoʻī i loko o kou kino, e hāʻawi ana i ke kōkua mai nā maʻi e like me ka rheumatoid arthritis, psoriasis, a me ka maʻi ʻōpū mumū.

No kēia lāʻau lapaʻau i kahi papa i kapa ʻia ʻo TNF blockers, e hana ana ma ka ʻimi ʻana i ka tumor necrosis factor-alpha, kahi protein e hoʻoulu ai i ka mumū a me ka pōʻino hui ke loaʻa i ka nui. E noʻonoʻo iā ia e like me ka hoʻokomo ʻana i kahi kaʻa mālie ma ka pane mumū o kāu ʻōnaehana pale.

He aha ʻo Adalimumab-aqvh?

ʻO Adalimumab-aqvh he mana biosimilar o ka lāʻau adalimumab kumu, ʻo ia hoʻi ua like loa ia i ke ʻano a me ka hana akā ua hana ʻia e kahi mea hana ʻē aʻe. ʻO ka ʻāpana

• ʻĀʻīhūhū rheumatoid - Hoʻēmi i ka ʻeha hui, pehu, a pale i ka pōʻino hui i ka wā lōʻihi
• ʻĀʻīhūhū psoriatic - Kōkua i nā hōʻailona hui a me nā ʻili ʻili
• Ankylosing spondylitis - Hoʻomāmā i ka ʻeha kua a me ka ʻoʻoleʻo mai ka mumū o ke kuamoʻo
• Maʻi ʻo Crohn - Hoʻēmi i ka mumū o ka ʻōpū a paipai i ka hoʻōla
• Ulcerative colitis - Kōkua i ka mālama ʻana i ka mumū o ka ʻōpū nui a me nā hōʻailona
• Plaque psoriasis - Hoʻomaʻemaʻe i nā ʻili ʻili a hoʻēmi i ka unahi
• Hidradenitis suppurativa - Hoʻēmi i nā puʻupuʻu ʻili ʻeha a me nā abscesses

Na kāu kauka e hoʻoholo inā kūpono ka adalimumab-aqvh no kou maʻi kikoʻī e pili ana i kāu mau hōʻailona, ​​moʻolelo olakino, a pehea ʻoe i pane ai i nā lāʻau lapaʻau ʻē aʻe. Nui ka poʻe i ʻike i ka hōʻoluʻolu nui ke hāʻawi ʻole nā ​​lāʻau lapaʻau ʻē aʻe i ka mana kūpono.

Pehea e hana ai ʻo Adalimumab-aqvh?

Hana ʻo Adalimumab-aqvh ma ka pale ʻana i ka tumor necrosis factor-alpha (TNF-alpha), he protein e hana nui i ka hana ʻana i ka mumū i loko o kou kino. Ke loaʻa iā ʻoe kahi maʻi autoimmune, hana kou kino i ka nui o kēia protein, e alakaʻi ana i nā hōʻailona ʻeha āu e ʻike ai.

Ua manaʻo ʻia kēia lāʻau lapaʻau he mea hoʻopau i ka pale ʻana i ka waena, ʻo ia hoʻi e hoʻēmi ana i ka hana o kāu ʻōnaehana pale i kahi ala i manaʻo ʻia. ʻAʻole like me kekahi mau lāʻau lapaʻau e kāohi ākea i ka pale ʻana, ua manaʻo ʻo adalimumab-aqvh i ke ala mumū e hana nei i kāu mau hōʻailona.

E hoʻomaka ana ʻoe e ʻike i nā hoʻomaikaʻi ʻana i loko o 2-4 mau pule o ka hoʻomaka ʻana i ka lāʻau lapaʻau, ʻoiai e ʻike paha kekahi poʻe i nā loli ma mua a ma hope paha. Hoʻomohala maʻamau ka hopena therapeutic piha ma luna o 3-6 mau mahina i ka wā e kūkulu ai ka lāʻau lapaʻau i loko o kāu ʻōnaehana a hoʻomaka e kāohi pono i ka mumū.

Pehea wau e lawe ai iā Adalimumab-aqvh?

Hāʻawi ʻia ʻo Adalimumab-aqvh ma ke ʻano he injection subcutaneous, āu e aʻo ai e hāʻawi iā ʻoe iho ma ka home ma hope o ke aʻo kūpono mai kāu hui mālama ola. Hoʻokomo ka hapa nui o nā kānaka iā ia i loko o ko lākou ʻūhā a i ʻole ka ʻōpū, e hoʻololi ana i nā wahi injection e pale ai i ka huhū o ka ʻili.

He ʻokoʻa ka papa manawa maʻamau e pili ana i kou kūlana, akā loaʻa i ka hapa nui o nā kānaka nā injections i kēlā me kēia pule ʻē aʻe. E hoʻomaka kāu kauka iā ʻoe ma ka mahele kūpono e pili ana i kāu hōʻailona kikoʻī a hiki ke hoʻololi iā ia i ka manawa e pili ana i ke ʻano o kāu pane.

Ma mua o kēlā me kēia injection, e ʻae i ka lāʻau lapaʻau e hiki i ka mahana o ka lumi no kahi o 15-30 mau minuke. Hana kēia i ka injection ʻoi aku ka ʻoluʻolu a hōʻoia i ka hana pono ʻana o ka lāʻau lapaʻau. ʻAʻole pono ʻoe e lawe me ka meaʻai a i ʻole e pale i ka ʻai ʻana ma mua o kāu injection.

E mālama i kāu lāʻau lapaʻau i loko o ka pahu hau ma waena o 36-46°F (2-8°C) a pale iā ia mai ka mālamalama. Mai hoʻokuʻu i ka adalimumab-aqvh a i ʻole e lulu ikaika i ka vial, no ka mea hiki i kēia ke hōʻino i ke ʻano protein.

Pehea ka lōʻihi e lawe ai au i ka Adalimumab-aqvh?

He ʻokoʻa ka lōʻihi o ka mālama ʻana i ka adalimumab-aqvh mai kēlā me kēia kanaka, akā pono ka hapa nui o nā kānaka me nā maʻi autoimmune i ka lāʻau lōʻihi e mālama i ka mana o ka hōʻailona. Hiki i kekahi poʻe ke hoʻohana iā ia no kekahi mau makahiki, ʻoiai pono kekahi poʻe iā ia no ka manawa pau ʻole.

E nānā mau kāu kauka i kāu pane ʻana i ka lāʻau lapaʻau a hiki ke hoʻololi i kāu hoʻolālā therapy e pili ana i ka maikaʻi o ka mālama ʻia ʻana o kāu mau hōʻailona. Inā maikaʻi ʻoe a paʻa kou kūlana, hiki iā ʻoe ke hoʻomau i ka mahele like no nā manawa lōʻihi.

Hiki i kekahi poʻe ke hoʻokaʻawale i nā injections ma kahi mamao a i ʻole e hooki i ka lāʻau lapaʻau inā komo ko lākou kūlana i ke kala ʻana. Eia naʻe, ʻo ka hooki ʻana i ka wā mua e alakaʻi pinepine i ka hoʻi ʻana o ka hōʻailona, ​​no laila he mea nui e hana kokoke me kāu hui mālama ola i ka manawa.

He aha nā hopena ʻaoʻao o Adalimumab-aqvh?

He nui ka poʻe e ʻae maikaʻi ana iā adalimumab-aqvh, akā e like me nā lāʻau lapaʻau a pau, hiki iā ia ke hana i nā hopena ʻaoʻao i kekahi poʻe. ʻO ka mea maikaʻi, ʻaʻole maʻamau nā hopena ʻaoʻao koʻikoʻi, a he nui ka poʻe e ʻike wale i nā hōʻailona maʻalahi a hiki ke mālama ʻia.

ʻO nā hopena ʻaoʻao maʻamau āu e ʻike ai, penei:

• Nā hopena ma kahi o ka pahu - ʻUlaʻula, pehu, a i ʻole ka ʻeha maʻalahi ma kahi āu e pahu ai
• Nā maʻi hanu luna - Nā hōʻailona e like me ke anu a i ʻole ka paʻa ʻana o ka sinus
• Poʻo - Maʻamau maʻalahi a me ka manawa
• Pāpaʻa a i ʻole nā hopena ʻili - Maʻamau maʻalahi a me ka wahi
• Luhi - ʻOi aku ka luhi ma mua o ka maʻamau, ʻoiai ke hoʻomaka ʻana i ka lāʻau lapaʻau

ʻO nā hopena ʻaoʻao liʻiliʻi akā ʻoi aku ka koʻikoʻi e koi i ka lāʻau lapaʻau koke. Pākuʻi ʻia kēia mau hōʻailona o ka maʻi koʻikoʻi e like me ke kuni, nā anu, a i ʻole nā hōʻailona e like me ka maʻi flu, no ka mea, hiki i ka lāʻau lapaʻau ke hoʻonui iā ʻoe i nā maʻi.

ʻO nā hopena ʻaoʻao laha akā koʻikoʻi e pili ana i nā hopena maʻi koʻikoʻi, nā pilikia o ke ake, nā maʻi koko, a i ʻole nā pilikia o ka ʻōnaehana nerve. E nānā mau kāu kauka iā ʻoe me nā hoʻokolohua koko a me nā nānā ʻana e hopu i nā pilikia hiki ke hiki i ka wā.

ʻO wai ka mea ʻaʻole pono e lawe iā Adalimumab-aqvh?

ʻAʻole kūpono ʻo Adalimumab-aqvh no nā mea a pau, ʻoiai ka poʻe me nā maʻi hana a i ʻole kekahi mau maʻi olakino e hiki ke hōʻino ʻia e ka hoʻopaʻa ʻana i ka pale ʻana. E loiloi pono kāu kauka i kāu mōʻaukala olakino ma mua o ke kau ʻana i kēia lāʻau lapaʻau.

ʻAʻole pono ʻoe e lawe iā adalimumab-aqvh inā loaʻa iā ʻoe:

\n
• Nā maʻi e ola nei - Me ka maʻi tuberculosis, hepatitis B a i ʻole C, a i ʻole nā maʻi bacteria, viral, a i ʻole fungal koʻikoʻi
\n
• Nā maʻi maʻi i nā lāʻau lapaʻau ola - A i ʻole inā ua loaʻa iā ʻoe nā lāʻau lapaʻau ola i kēia manawa
\n
• ʻO ka maʻi puʻuwai koʻikoʻi - No ka mea hiki i ka lāʻau lapaʻau ke hoʻonui i kēia maʻi
\n
• Mōʻaukala o ka lymphoma a i ʻole nā maʻi ʻē aʻe - ʻOi aku ka maʻi koko
\n
• Multiple sclerosis - A i ʻole nā maʻi demyelinating ʻē aʻe
\n

Eia kekahi, ʻo ka poʻe me nā ʻōnaehana pale i hoʻopilikia ʻia, nā maʻi maʻi mau, a i ʻole ka poʻe e lawe ana i kekahi mau lāʻau lapaʻau immunosuppressive ʻē aʻe e pono paha i ka nānā kūikawā a i ʻole nā lāʻau lapaʻau ʻē aʻe. E loiloi kāu kauka i nā pōmaikaʻi e kūʻē i nā pilikia hiki ke loaʻa no kou kūlana.

Nā inoa inoa Adalimumab-aqvh

Hoʻolaha ʻia ʻo Adalimumab-aqvh ma lalo o ka inoa inoa Hyrimoz ma ka hapa nui o nā ʻāina. Ua hoʻomohala ʻia kēia biosimilar e hāʻawi i kahi koho ʻoi aku ka maikaʻi i ka lāʻau adalimumab mua me ka mālama ʻana i ka pono therapeutic like.

Hiki nō hoʻi iā ʻoe ke lohe i nā mea mālama ola e kuhikuhi ana iā ia ma ke ʻano he

Hana nā lāʻau lapaʻau olaola ʻaʻole TNF e like me rituximab, abatacept, a i ʻole tocilizumab ma o nā ʻano hana like ʻole a he kūpono paha inā ʻaʻole pono nā mea pale TNF iā ʻoe. Hoʻohana pinepine ʻia nā lāʻau lapaʻau antirheumatic e hoʻololi ana i ka maʻi (DMARDs) e like me methotrexate me nā biologics a i ʻole ma kahi o lākou.

Ua ʻoi aku ka maikaʻi o Adalimumab-aqvh ma mua o Humira?

Ua manaʻo ʻia ʻo Adalimumab-aqvh a me Humira (ka adalimumab kumu) he mea like therapeutic, ʻo ia hoʻi, hana like lākou no ka mālama ʻana i nā maʻi autoimmune. He nui nā hoʻokolohua e hana ʻia ana i ka mana biosimilar e hōʻoia i ka like ʻana o ka pono a me ka palekana o ka lāʻau lapaʻau kumu.

ʻO ka pōmaikaʻi nui o adalimumab-aqvh ʻo ia ka mālama kālā, no ka mea, ʻoi aku ka liʻiliʻi o nā biosimilars ma mua o nā lāʻau lapaʻau kumu. Hiki i kēia ke maʻalahi i ka mālama ʻana a hoʻemi i kāu mau lilo mai kāu ʻeke, ʻoiai inā pono ʻoe i ka lāʻau lapaʻau lōʻihi.

Hopohopo kekahi poʻe e pili ana i ka hoʻololi ʻana mai ka lāʻau lapaʻau kumu i kahi biosimilar, akā hōʻike nā haʻawina lapaʻau e mālama ka poʻe e hoʻololi i ka pae like o ka mana o ka hōʻailona. Hiki i kāu kauka ke kōkua i ka hoʻoponopono ʻana i nā hopohopo āu e pili ana i ka hana ʻana i kēia hoʻololi.

Nā nīnau i nīnau pinepine ʻia e pili ana iā Adalimumab-aqvh

He palekana anei ʻo Adalimumab-aqvh no ka poʻe me ka maʻi diabetes?

Hiki ke hoʻohana palekana ʻia ʻo Adalimumab-aqvh i ka poʻe me ka maʻi diabetes, akā pono ia i ka nānā pono ʻana. ʻAʻole pili pololei ka lāʻau lapaʻau i nā pae kōpaʻa koko, akā hiki i nā maʻi (ʻoi aku ka maʻalahi i ka wā e lawe ana ʻoe) ke paʻakikī i ka mālama ʻana i ka maʻi diabetes.

E hana pū kāu kauka me ʻoe e hōʻoia i ka mālama maikaʻi ʻana o kāu maʻi diabetes i ka wā e loaʻa ana iā ʻoe ka lāʻau lapaʻau. Hiki i kēia ke komo i ka nānā pinepine ʻana i ke kōpaʻa koko a me ka hoʻopili ʻana ma waena o kāu rheumatologist a me endocrinologist.

He aha kaʻu e hana ai inā hoʻohana hewa au i ka nui o Adalimumab-aqvh?

Inā ua hoʻokomo hewa ʻoe i ka adalimumab-aqvh ʻoi aku ma mua o ka mea i kauoha ʻia, e kelepona koke i kāu kauka a i ʻole ke kauka mālama ola. ʻOiai ʻaʻohe lāʻau kūʻē kikoʻī no ka overdose, pono i kāu hui lapaʻau e nānā iā ʻoe no ka piʻi ʻana o ka pilikia o nā maʻi a i ʻole nā pilikia ʻē aʻe.

Mai hopohopo, akā e ʻimi koke i ka ʻōlelo aʻo lapaʻau. Hiki i kāu kauka ke makemake e ʻike iā ʻoe no ka loiloi a hiki ke hoʻololi i kāu papa hana nānā e nānā i nā hopena ʻino mai ka mahele kiʻekiʻe.

He aha kaʻu e hana ai inā ua hala wau i kahi mahele o Adalimumab-aqvh?

Inā ua hala ʻoe i kahi mahele, e lawe iā ia i ka wā e hoʻomanaʻo ai ʻoe, a laila e hoʻomau me kāu papa hana maʻamau. Eia naʻe, inā kokoke ka manawa no kāu mahele i hoʻonohonoho ʻia e hiki mai ana, e lele i ka mea i hala a e hoʻomau me kāu papa hana dosing maʻamau.

Mai pāpālua i nā mahele e hoʻopiha i kahi injection i hala. Akā, e kelepona i kāu mea mālama ola no ke alakaʻi ʻana i ke ala e hoʻi ai i ke ala me kāu papa hana lapaʻau.

I ka manawa hea e hiki ai iaʻu ke hooki i ka lawe ʻana iā Adalimumab-aqvh?

Mai hooki i ka lawe ʻana iā adalimumab-aqvh me ka ʻole e kūkākūkā mua i kāu kauka, ʻoiai inā ʻoe e ʻoi aku ka maikaʻi. ʻO ka hooki ʻana i ka lapaʻau e alakaʻi pinepine i nā hōʻailona flare-ups, a hiki ke lawe i nā pule a i ʻole nā mahina e loaʻa hou ka mana ke hoʻomaka hou ʻoe.

E kōkua kāu kauka iā ʻoe e hoʻoholo i ka manawa kūpono e noʻonoʻo ai e hooki a hoʻemi paha i kāu mahele e pili ana i kāu mana hōʻailona, ​​nā hopena hana koko, a me ke kūlana olakino holoʻokoʻa. Pono paha kekahi poʻe e hoʻomau i ka lapaʻau no ka wā lōʻihi e mālama i ka remission.

Hiki iaʻu ke loaʻa nā lāʻau lapaʻau i ka wā e lawe ana iā Adalimumab-aqvh?

Pono ʻoe e pale i nā lāʻau lapaʻau ola i ka wā e lawe ana iā adalimumab-aqvh, no ka mea, hiki iā lākou ke hoʻoulu i nā maʻi i ka poʻe me nā ʻōnaehana pale i hoʻopaʻa ʻia. Eia naʻe, palekana a paipai ʻia nā lāʻau lapaʻau i hoʻopau ʻia (e like me nā pana flu).

E kamaʻilio me kāu kauka e pili ana i kāu papa hana hoʻopaʻa ʻia ma mua o ka hoʻomaka ʻana i ka lāʻau lapaʻau. Hiki iā lākou ke ʻōlelo aku e kiʻi i kekahi mau lāʻau lapaʻau ma mua o kou hoʻomaka ʻana i ka adalimumab-aqvh, a e kōkua lākou iā ʻoe e noho i kēia manawa ma nā lāʻau lapaʻau palekana i ka wā e loaʻa ana iā ʻoe ka lāʻau lapaʻau.